Quantum Genesis AI (QTZM) Shares Outstanding (Weighted Average) (2016 - 2026)
Quantumzyme's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $41.0 million for Q1 2026.
- For Q1 2026, Shares Outstanding (Weighted Average) rose 16.14% year-over-year to $41.0 million; the TTM value through Jan 2026 reached $41.0 million, up 16.14%, while the annual FY2025 figure was $39.0 million, 12.03% up from the prior year.
- Shares Outstanding (Weighted Average) reached $41.0 million in Q1 2026 per QTZM's latest filing, up from $500.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $41.0 million in Q1 2026 to a low of $500.0 in Q4 2024.
- Average Shares Outstanding (Weighted Average) over 3 years is $26.5 million, with a median of $35.3 million recorded in 2025.
- Peak YoY movement for Shares Outstanding (Weighted Average): changed 0.0% in 2025, then rose 16.14% in 2026.
- A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $500.0 in 2024, then changed by 0.0% to $500.0 in 2025, then soared by 8194310.0% to $41.0 million in 2026.
- Per Business Quant, the three most recent readings for QTZM's Shares Outstanding (Weighted Average) are $41.0 million (Q1 2026), $500.0 (Q4 2025), and $39.0 million (Q3 2025).